Source: World Health Organization (WHO) |

The Access to COVID-19 Tools (ACT) Accelerator partnership welcomes commitment of 870 million vaccine doses and calls for more investment in all tools to end the pandemic

870 million vaccine doses for low and low-middle income countries over the next year

G7 leaders donate 870 million vaccine doses for low and low-middle income countries over the next year, vital for reducing virus transmission; G7 leaders emphasize the importance of all ACT-Accelerator tools to exit the pandemic; ACT-Accelerator’s funding gap remains significant with an urgent need for funding of tests, treatments and health…

Source: World Health Organization (WHO) |

Coronavirus: COVAX announces new agreement, plans for first deliveries

COVAX announced that, pending WHO emergency use listings, nearly 150 million doses of the AstraZeneca/Oxford candidate are anticipated to be available in Q1 2021

COVAX announced the signing of an advance purchase agreement for up to 40 million doses of the Pfizer-BioNTech vaccine; rollout to commence with successful execution of supply agreements; additionally, COVAX announced that, pending WHO emergency use listings, nearly 150 million doses of the AstraZeneca/Oxford candidate are anticipated to be available…

Source: World Health Organization (WHO) |

Coronavirus Global Response: Access to COVID-19 Tools-Accelerator Facilitation Council holds inaugural meeting

The ACT-Accelerator is the proven, up-and-running, global collaboration accelerating the development, production, and equitable access to COVID-19 tests, treatments, and vaccines

United Nations Secretary General António Guterres appeals for a quantum leap in funding for the ACT-Accelerator, a global solution to get the world moving, working and prospering again -         H.E. Cyril Ramaphosa, President of South Africa, and H.E. Erna Solberg, Prime Minister of Norway, co-chair the ACT-Acceleration Facilitation Council -        …

Source: World Health Organization (WHO) |

Coronavirus - Africa: 172 Countries & Multiple Candidate Vaccines engaged in COVID-19 Vaccine Global Access Facility

Goal of bringing the pandemic under control via equitable access to COVID-19 vaccines needs urgent, broadscale commitment and investment from countries

Nine CEPI-supported candidate vaccines are part of the COVAX initiative, with a further nine candidates under evaluation, and procurement conversations on-going with additional producers not currently receiving research and development (R&D) funding through COVAX – giving COVAX the largest and most diverse COVID-19 vaccine portfolio in the world; 80 potentially…

Source: World Health Organization (WHO) |

Coronavirus - Africa: WHO and UNICEF warn of a decline in vaccinations during COVID-19

This is due to disruptions in the delivery and uptake of immunization services caused by the COVID-19 pandemic

WHO and UNICEF call for immediate efforts to vaccinate all children as new data shows that, before the COVID-19 pandemic, vaccine coverage stalled at 85 per cent for nearly a decade, with 14 million unvaccinated infants yearly The World Health Organization and UNICEF warned today of an alarming decline in…

World Health Organization (WHO)
  • Multimedia content

  • Images (1)
    • Coronavirus - Africa: The vaccines success story gives us hope for the future
  • All (1)
Source: World Health Organization (WHO) |

Coronavirus - Africa: The vaccines success story gives us hope for the future

Vaccines remain the safest, most cost-effective protection against disease and will provide a powerful tool to address the COVID-19 pandemic

The World Health Organization (WHO), working in partnership with both public and private sectors, has a proud history of vaccinology. By assessing vaccines for global supply, WHO’s groundbreaking Prequalification programme has made possible the deployment of quality-assured, safe and effective vaccines to dozens of countries across the world. This programme…

Source: World Health Organization (WHO) |

Coronavirus - Africa: Commemorating Smallpox Eradication – a legacy of hope, for COVID-19 and other diseases

The declaration marked the end of a disease that had plagued humanity for at least 3 000 years, killing 300 million people in the 20th century alone

On 8 May 1980, the 33rd World Health Assembly officially declared: ‘The world and all its peoples have won freedom from smallpox.’ The declaration marked the end of a disease that had plagued humanity for at least 3 000 years, killing 300 million people in the 20th century alone.  It was…

Source: World Health Organization (WHO) |

Advocates around the World #SpeakUp for #RoadSafety

Despite progress, road traffic deaths continue to rise, with an annual 1.35 million fatalities

In the context of the Fifth UN Global Road Safety Week (6-12 May 2019), thousands of road safety advocates from around the world are highlighting the need for more effective leadership for road safety. Strong leaders - both government and nongovernment alike - are those who #SpeakUp for road safety…

Source: World Health Organization (WHO) |

Ten threats to global health in 2019

Ten health issues WHO will tackle this year

The world is facing multiple health challenges. These range from outbreaks of vaccine-preventable diseases like measles and diphtheria, increasing reports of drug-resistant pathogens, growing rates of obesity and physical inactivity to the  health impacts of environmental pollution and climate change and multiple humanitarian crises.    To address these and other…

Source: World Health Organization (WHO) |

WHO and partners launch new country-led response to put stalled malaria control efforts back on track

Reductions in malaria cases have stalled after several years of decline globally, according to the new World malaria report 2018

To get the reduction in malaria deaths and disease back on track, the World Health Organization (WHO) and partners are joining a new country-led response, launched today, to scale up prevention and treatment, and increased investment, to protect vulnerable people from the deadly disease. For the second consecutive year, the…